CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression

Abstract Currently, radiotherapy is one of the most attractive treatments for prostate cancer (PCa) patients. However, radioresistance remains a challenging issue and the underlying mechanism is unknown. Growing evidence has demonstrated that CDC20 (Cell division cycle protein 20) plays a pivotal ro...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Yang, Chuanlai [verfasserIn]

Ge, Yuegang

Zang, Yachen

Xu, Ming

Jin, Lu

Wang, Yang

Xu, Xinyu

Xue, Boxin

Wang, Zhiwei

Wang, Lixia

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2023

Schlagwörter:

Prostate cancer

CDC20

Twist1

Radiosensitivity

Carcinogenesis

Anmerkung:

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:

Enthalten in: Apoptosis - Dordrecht [u.a.] : Springer Science + Business Media B.V, 1996, 28(2023), 11-12 vom: 03. Aug., Seite 1584-1595

Übergeordnetes Werk:

volume:28 ; year:2023 ; number:11-12 ; day:03 ; month:08 ; pages:1584-1595

Links:

Volltext

DOI / URN:

10.1007/s10495-023-01877-7

Katalog-ID:

SPR053585739

Nicht das Richtige dabei?

Schreiben Sie uns!